Tandem Diabetes Care, Inc.
TNDMNASDAQHealthcareMedical Devices
As of Oct 16, 2026 close
- Market cap
- $1.14B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $12.26$29.65
- Volume (live)
- -
- Avg. volume (3M)
- 2.24M
Tandem Diabetes Care (TNDM) Stock Price & Financial Analysis
Tandem Diabetes Care Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $16.14 - $17.25 |
|---|---|
| 52-Week High | $29.65 |
| 52-Week Low | $12.26 |
| Open | $16.61 |
| Volume (last close) | 1.63M |
| Average Volume (3M) | 2.24M |
| Revenue (TTM) | 1.04B |
|---|---|
| Net Income (TTM) | -63.31M |
| Free Cash Flow (TTM) | -26.62M |
| EPS (TTM) | −$0.93 |
| Profit Margin | -6.08% |
| Operating Margin | -4.13% |
| Return on Equity (ROE) | -48.56% |
| Debt to Equity | 4.78 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.14B |
|---|---|
| Shares Outstanding | 69.01M |
| Price to Sales (P/S) | 1.09 |
| Price to Book (P/B) | 8.74 |
| EV/EBITDA | -55.92 |
| 50-Day MA | $19.12 |
|---|---|
| 200-Day MA | $19.19 |
| 1-Year Change | +11.70% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Tandem Diabetes Care at a Glance
As of the Oct 16, 2026 close, Tandem Diabetes Care (TNDM) has a market capitalization of $1.14B. The stock trades at 1.1× sales. Over the trailing twelve months it lost $63.31M on revenue of $1.04B and burned $26.62M of free cash flow. Revenue grew 4.0% year over year.
As of its latest reported balance sheet, it holds $62.82M in cash and securities against $622.84M of debt, a net debt position of $560.02M.
Tandem Diabetes Care does not currently pay a dividend.
The share price is up 11.7% over the past year. At $16.24 (the Oct 16, 2026 close) it sits within its 52-week range of $12.26 to $29.65, below its 200-day moving average of $19.19.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $26.77, 64.8% above the Oct 16, 2026 close.
Frequently Asked Questions About Tandem Diabetes Care
What is the current stock price for TNDM?
As of the Oct 16, 2026 close, TNDM stock trades at $16.24. The 52-week range is $12.26–$29.65, with a day range of $16.14–$17.25.
What is the P/E ratio for TNDM?
The P/E ratio (Price-to-Earnings) for TNDM is shown in the Key Statistics section. This valuation metric helps compare Tandem Diabetes Care, Inc. to industry peers.
Does TNDM pay dividends?
Tandem Diabetes Care does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TNDM?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for TNDM is Buy. The average 12-month price target is $26.77, a 64.8% upside from the Oct 16, 2026 close of $16.24.
What is the market cap of TNDM?
As of the Oct 16, 2026 close, Tandem Diabetes Care's market capitalization is $1.12B, classifying it as a small-cap company. Tandem Diabetes Care operates in the Healthcare sector within the Medical Devices industry.